Michael Rose to Adult
This is a "connection" page, showing publications Michael Rose has written about Adult.
Connection Strength
0.505
-
Validity of Fitbit activity monitoring for adults with progressive muscle diseases. Disabil Rehabil. 2022 Dec; 44(24):7543-7553.
Score: 0.055
-
The validity of the International Physical Activity Questionnaire (IPAQ) for adults with progressive muscle diseases. Disabil Rehabil. 2022 Nov; 44(23):7312-7320.
Score: 0.055
-
Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome. Clin Breast Cancer. 2019 12; 19(6):423-432.e5.
Score: 0.047
-
SIGECAPS, SSRIs, and Silence - Life as a Depressed Med Student. N Engl J Med. 2018 Mar 22; 378(12):1081-1083.
Score: 0.043
-
What explains high life satisfaction in men living with Duchenne muscular dystrophy? A preliminary study to inform psychological intervention. Muscle Nerve. 2017 07; 56(1):163-166.
Score: 0.040
-
Activity rating scales in adult muscle disease: what do they actually measure? Muscle Nerve. 2014 Jul; 50(1):14-23.
Score: 0.032
-
Activity rating scales in adult muscle disease: how well do they actually measure? Muscle Nerve. 2014 Jul; 50(1):24-33.
Score: 0.032
-
A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease. Clin Rehabil. 2014 May; 28(5):508-19.
Score: 0.032
-
Role of disease severity, illness perceptions, and mood on quality of life in muscle disease. Muscle Nerve. 2012 Sep; 46(3):351-9.
Score: 0.029
-
Does aging stop? Curr Aging Sci. 2009 Mar; 2(1):3-11.
Score: 0.023
-
Gulf War service is an uncertain trigger for ALS. Neurology. 2003 Sep 23; 61(6):730-1.
Score: 0.016
-
The BODY-Q Stretch Marks Scale: A Development and Validation Study. Aesthet Surg J. 2018 Aug 16; 38(9):990-997.
Score: 0.011
-
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget. 2016 Nov 01; 7(44):71429-71439.
Score: 0.010
-
Interventions for dysphagia in long-term, progressive muscle disease. Cochrane Database Syst Rev. 2016 Feb 09; 2:CD004303.
Score: 0.009
-
The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population. Muscle Nerve. 2015 Apr; 51(4):496-500.
Score: 0.009
-
Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve. 2014 Mar; 49(3):422-30.
Score: 0.008
-
Separating emotions from consequences in muscle disease: comparing beneficial and unhelpful illness schemata to inform intervention development. J Psychosom Res. 2013 Apr; 74(4):320-6.
Score: 0.007
-
Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology. 2012 Sep 11; 79(11):1145-54.
Score: 0.007
-
Attention modulates spinal cord responses to pain. Curr Biol. 2012 Jun 05; 22(11):1019-22.
Score: 0.007
-
Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK. Health Qual Life Outcomes. 2011 Dec 16; 9:114.
Score: 0.007
-
A systematic review of quality of life in adults with muscle disease. J Neurol. 2011 Sep; 258(9):1581-92.
Score: 0.007
-
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.
Score: 0.006
-
Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2010 Mar; 20(3):166-73.
Score: 0.006
-
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007 Aug; 130(Pt 8):2024-36.
Score: 0.005
-
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004 May; 14(5):337-45.
Score: 0.004